treatment
News
2021.05.20
Rabies is still responsible for approximately 60,000 deaths in humans each year. The bat-borne virus EBL1a, related to rabies, rarely affects humans, but a...
Document de presse
2021.05.12
Inserm teams led by Laurent Reber (Infinity, Toulouse) and Pierre Bruhns (Humoral Immunity, Institut Pasteur, Paris) and French company NEOVACS have developed...
News
2020.10.16
Hantaviruses are rodent-borne viruses causing serious zoonotic outbreaks worldwide for which no treatment is available. X-ray structures of the hantavirus...
News
2020.08.04
Resistance to artemisinin, the main component of current antimalarial treatments recommended by WHO, is widespread in South-East Asia, but has not been...
News
2021.05.05
Malaria remains a major public health burden in some world regions. In 2018, 237,000 cases were reported in Brazil, 91.5% of them caused by the parasite...
News
2021.03.30
Immunotherapy, or the notion of "retraining" patients' immune systems, constitutes a major step forward in the fight against cancer. Although the results of...
News
2021.03.24
ERA4TB (the European Regimen Accelerator for Tuberculosis) is a 6-year public-private partnership with a total budget of over €200M that began in 2020 with the...
News
2021.03.01
The Institut Pasteur's Systems Biology Group is a partner in a new international project on applications of artificial intelligence (AI) for the diagnosis and...
News
2021.03.01
The Institut Pasteur's Biological Image Analysis Unit is taking part in a new project selected by the EU's Innovative Medicines Initiative. The project,...
News
2021.02.02
Cancer is the leading cause of mortality in France. In the last 40 years, survival rates have increased for several types of cancer, such as breast or prostate...